After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 112 big blue chips.
Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
This Week’s Ratings Changes:
More From InvestorPlace
- 9 Stocks That Have No More Profits Left for You
- The Top 10 S&P 500 Dividend Stocks to Buy Now
- 7 Healthcare Stocks That Are Investor Poison